IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Artia Global Partners LP

Q3 2023 Holdings

Filed 2023-11-14 | 27 holdings | $240.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Novo-Nordisk A S(NVO)ADR670100205$62.0M681,81225.8%
Merck & Co Inc(MRK)COM58933Y105$33.9M329,20014.1%
Argenx SE(ARGX)SPONSORED ADR04016X101$24.2M49,23810.1%
Lilly ELI & Co(LLY)COM532457108$14.1M26,1935.8%
Abbvie Inc(ABBV)COM00287Y109$13.5M90,8215.6%
Astrazeneca PLC(AZN)SPONSORED ADR046353108$12.9M190,7525.4%
Seagen Inc(SGENUSD)COM81181C104$10.9M51,1754.5%
Roivant Sciences LTD(ROIV)SHSG76279101$10.7M914,0234.4%
89Bio Inc(ETNBGBP)COM282559103$7.2M465,4653.0%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$6.9M78,4652.9%
Sarepta Therapeutics Inc(SRPT)COM803607100$6.9M57,1622.9%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$6.4M18,3142.6%
Axsome Therapeutics Inc(AXSM)COM05464T104$6.1M87,8482.6%
Neurocrine Biosciences Inc(NBIX)COM64125C109$5.1M45,0002.1%
Viking Therapeutics Inc(VKTX)COM92686J106$4.2M383,5801.8%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$2.8M15,9711.2%
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$2.2M41,6000.9%
Vaxcyte Inc(PCVX)COM92243G108$2.0M38,5550.8%
Protagonist Therapeutics Inc(PTGX)COM74366E102$1.9M112,3400.8%
Pliant Therapeutics Inc(PLRX)COM729139105$1.7M100,0000.7%
Charles RIV Labs Intl Inc(CRL)COM159864107$1.4M6,9050.6%
Thermo Fisher Scientific Inc(TMO)COM883556102$1.1M2,1090.4%
Waters Corp(WAT)COM941848103$780.1K2,8450.3%
Tyra Biosciences Inc(TYRA)COM90240B106$623.1K45,2530.3%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$615.2K41,2610.3%
Biomea Fusion Inc(BMEA)COM09077A106$350.2K25,4520.1%
Gritstone BIO Inc(2JQ)COM39868T105$163.7K95,1700.1%